Cencora | COR - Cost Of Sales


Cencora reported $75.02B in Cost of Sales for its fiscal quarter ending in March of 2026.





Cost Of Sales Change Date
Ambu A/S DKK 625M 14M Mar/2026
Amplifon EUR 527.19M 77.51M Jun/2026
Apollo Hospitals Enterprise Ltd INR 36.26B 248M Mar/2026
Brookdale Senior Living USD 548.5M 94.81M Mar/2026
Cencora USD 75.02B 8.1B Mar/2026
Coloplast 2.31B 110M Dec/2025
Convatec Group USD 515.3M 270.15M Dec/2024
Diasorin EUR 101M 7.58M Mar/2026
Encompass Health USD 151.6M 700K Mar/2026
Enovis USD 265.09M 476K Jun/2026
GE HealthCare Technologies USD 3.15B 283M Mar/2026
Gulf Medical Proj AED 147.27M 3.78M Mar/2026
Hoya 209.52B 170.6B Jun/2026
Med Life RON 171.54M 112.24M Mar/2026
Oriola-kd EUR 11.4M 450.2M Mar/2026
Rede D'or Sao Luiz BRL 11.12B 4.84B Mar/2026
Siemens Healthineers EUR 3.31B 226M Jun/2026
Solventum Corp USD 923M 12M Jun/2026
Sonova Holding CHF 539.4M 11.5M Dec/2025
Veradigm USD 124.74M 56.25M Dec/2022
Zimmer Biomet Holdings USD 815.9M 77.6M Jun/2026